Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

Long before she became a medical student, Emma Elder, '24 BSc (Hons), learned some tough lessons about the health-care system ...

MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.New data from the ARCHER ...

Country music star Carly Pearce opened up more about the frightening heart condition she revealed in 2024 during an appearance on “Today” earlier this year. The 35-year-old singer revealed last year ...

Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on ...

Kiniksa Pharmaceuticals International said the Food and Drug Administration has granted orphan drug designation to KPL-387 for the treatment of pericarditis, which includes recurrent pericarditis.

The FDA is pursuing leucovorin as a potential treatment for autism spectrum disorder. The medication is currently used as a cancer drug, among other things. Preliminary data suggests the medication ...